AI assistant
Sending…
CBIZ, Inc. — Director's Dealing 2020
Aug 4, 2020
31402_dirs_2020-08-04_6ce6514a-dc7a-4952-b83d-6660286023b8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CBIZ, Inc. (CBZ)
CIK: 0000944148
Period of Report: 2020-07-31
Reporting Person: Kouzelos Michael P (President, Employee Services)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-07-31 | Common Stock | M | 36000 | $9.35 | Acquired | 320184 | Direct |
| 2020-07-31 | Common Stock | S | 36000 | $23.3268 | Disposed | 284184 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-07-31 | Employee Stock Option | $9.35 | M | 36000 | Disposed | 2021-05-15 | Common Stock (36000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option | $10.35 | 2022-05-10 | Common Stock (72000) | 72000 | Direct |
| Employee Stock Option | $15.55 | 2023-05-10 | Common Stock (72000) | 72000 | Direct |
| Employee Stock Option | $19.45 | 2024-05-09 | Common Stock (72000) | 72000 | Direct |
| Restricted Stock Units | $0 | 2022-03-20 | Common Stock (19291) | 19291 | Direct |
| Restricted Stock Units | $0 | 2023-02-27 | Common Stock (14379) | 14379 | Direct |
Footnotes
F1: Exercise and sale of Employee Stock Options granted 05-15-15 at $9.35 exercise price, expiring 05-15-2021.
F2: Weighted average sale price of price range between $23.02 and $23.74. Will provide upon request number of shares sold at each separate price.
More from CBIZ, Inc.
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Annual Report
2026
Mar 2
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 25